Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients

Eszter Szarka, Fruzsina Babos, Anna Magyar, Krisztina Huber, Zoltán Szittner, Krisztián Papp, József Prechl, Judit Pozsgay, Zsuzsa Neer, Monika Ádori, György Nagy, Bernadette Rojkovich, Tamás Gáti, Judit Kelemen, Zsuzsanna Baka, Márta Brózik, Borbála Pazár, Gyula Poór, Ferenc Hudecz, Gabriella Sármay

Research output: Contribution to journalArticle

15 Citations (Scopus)


Anti-citrullinated peptide/protein antibodies (ACPAs) are highly sensitive and specific markers of rheumatoid arthritis (RA). Identification of peptide epitopes that may detect different subgroups of RA patients might have diagnostic and prognostic significance. We have investigated citrulline- and arginine-containing peptide pairs derived from filaggrin, collagen or vimentin, and compared this citrulline-peptide panel with the serological assays conventionally used to detect ACPAs. Furthermore, we studied if the same citrulline-peptides identify antibody-secreting cells in in vitro cultures of RA B cells. Recognition of citrulline- and arginine-containing filaggrin, vimentin and collagen peptide epitopes were tested by Multipin ELISA system, by indirect ELISA and by a peptide-specific microarray. B cells were purified from blood by negative selection; antibody-producing cells were enumerated by ELISPOT assay. The panel composed of citrulline-peptide epitopes of filaggrin, collagen and vimentin was recognized by RA sera with a sensitivity and specificity comparable with the currently used tests. Moreover, the combined citrulline-peptide panel including the new short epitope peptide of filaggrin, fil311-315, also identified nearly one-third of RA cases that were negative for antibodies against cyclic citrullinated peptides, mutated citrullinated vimentin or for rheumatoid factor. The results with the peptide-specific microarray have shown that although most ACPAs recognizing the four citrulline peptides are IgG, some of them specifically recognizing citrulline-containing filaggrin peptides (fil311-315 and fil306-326) are IgM, and so may be produced either by newly formed activated B cells or by unswitched B memory cells. Furthermore, the citrulline-peptides of filaggrin and vimentin detect ACPA-producing cells, and so could also be applied to study the B cells of RA patients.

Original languageEnglish
Pages (from-to)181-191
Number of pages11
Issue number2
Publication statusPublished - Feb 1 2014



  • Anti-citrullinated peptide antibodies
  • B cell
  • Citrulline-peptide
  • Diagnosis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Szarka, E., Babos, F., Magyar, A., Huber, K., Szittner, Z., Papp, K., Prechl, J., Pozsgay, J., Neer, Z., Ádori, M., Nagy, G., Rojkovich, B., Gáti, T., Kelemen, J., Baka, Z., Brózik, M., Pazár, B., Poór, G., Hudecz, F., & Sármay, G. (2014). Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients. Immunology, 141(2), 181-191.